首页|期刊导航|实用临床医药杂志|活血理气针刺法联合身痛逐瘀汤治疗气滞血瘀型腰椎间盘突出症的效果

活血理气针刺法联合身痛逐瘀汤治疗气滞血瘀型腰椎间盘突出症的效果OA

Effects of acupuncture for promoting blood circulation and regulating qi combined with Shentong Zhuyu Decoction in the treatment of lumbar disc herniation of qi stagnation and blood stasis type

中文摘要英文摘要

目的 探讨活血理气针刺法联合身痛逐瘀汤治疗气滞血瘀型腰椎间盘突出症(LDH)的效果.方法 将2022年1月—2024年3月收治的100例LDH患者根据治疗方案的不同分为对照组(常规对症支持治疗联合身痛逐瘀汤治疗)和联合组(常规对症支持治疗联合身痛逐瘀汤和活血理气针刺法治疗),每组50例.采用倾向性评分匹配法对2组资料进行1∶1匹配,最终2组各纳入48例患者.连续治疗6周后,比较2组患者临床疗效、中医证候积分、疼痛程度、腰椎功能、安全性及疾病复发情况.结果 联合组治疗总有效率为93.75%(45/48),高于对照组的79.17%(38/48),差异有统计学意义(P=0.037).治疗6周后,联合组主要证候积分为(13.35±1.63)分,次要证候积分为(5.14±0.58)分,低于对照组的(16.49±2.32)、(6.28±0.79)分,差异有统计学意义(P<0.05).联合组治疗4、6周时视觉模拟评分法(VAS)评分分别为(4.35±1.24)、(2.52±0.76)分,低于对照组的(4.89±1.35)、(3.42±1.14)分,差异有统计学意义(P<0.05).治疗后,联合组Oswestry功能障碍指数(ODI)评分为(10.58±1.87)分,低于对照组的(14.47±2.76)分,腰椎屈伸度、腰椎旋转度分别为(75.65±14.43)°、(39.67±9.25)°,高于对照组的(68.83±12.28)°、(35.49±8.37)°,差异有统计学意义(P<0.05).联合组不良反应发生率为16.67%(8/48),对照组不良反应发生率为12.50%(6/48),差异无统计学意义(P>0.05).治疗结束对治疗有效的患者随访6个月发现,治疗组复发率为8.89%(4/45),对照组复发率为15.79%(6/38),差异无统计学意义(P>0.05).结论 活血理气针刺法联合身痛逐瘀汤治疗气滞血瘀型LDH具有较好的临床疗效,可有效减轻患者腰腿痛症状,改善腰椎活动功能,且安全性良好.

Objective To investigate the efficacy of blood-activating and qi-regulating acupunc-ture combined with Shentong Zhuyu Decoction in the treatment of lumbar disc herniation(LDH)of qi stagnation and blood stasis type.Methods A total of 100 LDH patients admitted from January 2022 to March 2024 were divided into control group(conventional symptomatic supportive treatment com-bined with Shentong Zhuyu Decoction)and combination group(conventional symptomatic supportive treatment combined with Shentong Zhuyu Decoction and blood-activating and qi-regulating acupunc-ture)according to treatment regimens,with 50 cases in each group.Propensity score matching(PSM)method was used for 1∶1 matching of baseline data between the two groups,and finally 48 patients were included in each group.After 6 weeks of continuous treatment,clinical efficacy,traditional Chinese medicine syndrome scores,pain severity,lumbar function,safety,and disease recurrence were compared between the two groups.Results The total effective rate in the combination group was 93.75%(45/48),which was significantly higher than 79.17%(38/48)in the control group(P=0.037).After 6 weeks of treatment,the primary syndrome score and secondary syndrome score in the combination group were(13.35±1.63)and(5.14±0.58),respectively,which were significantly lower than(16.49±2.32)and(6.28±0.79)in the control group(P<0.05).The Visual Analogue Scale(VAS)scores at 4 and 6 weeks in the combination group were(4.35±1.24)and(2.52±0.76),respectively,which were significantly lower than(4.89±1.35)and(3.42±1.14)in the control group(P<0.05).After treatment,the Oswestry Disability Index(ODI)score in the combination group was(10.58±1.87),which was significantly lower than(14.47±2.76)in the control group,while the lumbar flexion-extension range and lumbar rotation range in the combination group were(75.65±14.43)° and(39.67±9.25)°,respectively,which were significantly higher than(68.83±12.28)° and(35.49±8.37)° in the control group(P<0.05).The incidence of adverse reactions in the combination group was 16.67%(8/48),and that in the control group was 12.50%(6/48),with no statistically significant difference(P>0.05).A 6-month follow-up of treatment-effective patients after treatment completion showed that the recur-rence rate in the treatment group was 8.89%(4/45),and that in the control group was 15.79%(6/38),with no statistically significant difference(P>0.05).Conclusion Blood-activating and qi-regulating acupuncture combined with Shentong Zhuyu Decoction demonstrates favorable clinical efficacy in treating LDH of qi stagnation and blood stasis type,can effectively alleviate lumbocrural pain symptoms,improve lumbar mobility function,exhibiting a good safety profile.

廉幸;张宾

安徽中医药大学附属太和中医院针灸科,安徽阜阳,236600安徽中医药大学附属太和中医院针灸科,安徽阜阳,236600

医药卫生

腰椎间盘突出症气滞血瘀型身痛逐瘀汤针刺法腰椎功能疼痛程度复发Oswestry功能障碍指数

lumbar disc herniationqi stagnation and blood stasis typeShentong Zhuyu De-coctionacupuncturelumbar functionpain severityrecurrenceOswestry Disability Index

《实用临床医药杂志》 2026 (16)

18-25,8

2020年度安徽省自然科学基金项目(2008085QH392)

10.7619/jcmp.20262168

评论